Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Dose-Ranging Study of INCB018424 Phosphate Cream in Subjects With Vitiligo

NCT03099304 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT03099304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03099304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Dose-Ranging Study of INCB018424 Phosphate Cream in Subjects With Vitiligo
Lead sponsor
Incyte Corporation
Phase
Phase 2
Overall status
Completed
Start date
June 7, 2017
Completion date
September 8, 2021
Enrollment
157 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

vitiligo